- Home
- HCAI vs THAR Comparison
HCAI vs THAR Comparison
Compare HCAI & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCAI
- THAR
- Stock Information
- Founded
- HCAI 2004
- THAR 2017
- Country
- HCAI China
- THAR United States
- Employees
- HCAI N/A
- THAR N/A
- Industry
- HCAI Miscellaneous manufacturing industries
- THAR Biotechnology: Pharmaceutical Preparations
- Sector
- HCAI Consumer Discretionary
- THAR Health Care
- Exchange
- HCAI Nasdaq
- THAR Nasdaq
- Market Cap
- HCAI 20.3M
- THAR 22.8M
- IPO Year
- HCAI 2025
- THAR 2022
- Fundamental
- Price
- HCAI $0.54
- THAR $3.24
- Analyst Decision
- HCAI
- THAR Strong Buy
- Analyst Count
- HCAI 0
- THAR 1
- Target Price
- HCAI N/A
- THAR $17.00
- AVG Volume (30 Days)
- HCAI 72.5K
- THAR 2.6M
- Earning Date
- HCAI 11-23-2025
- THAR 11-07-2025
- Dividend Yield
- HCAI N/A
- THAR N/A
- EPS Growth
- HCAI N/A
- THAR N/A
- EPS
- HCAI 0.00
- THAR N/A
- Revenue
- HCAI $19,176,987.00
- THAR N/A
- Revenue This Year
- HCAI N/A
- THAR N/A
- Revenue Next Year
- HCAI N/A
- THAR N/A
- P/E Ratio
- HCAI $159.56
- THAR N/A
- Revenue Growth
- HCAI N/A
- THAR N/A
- 52 Week Low
- HCAI $0.47
- THAR $0.95
- 52 Week High
- HCAI $10.97
- THAR $9.08
- Technical
- Relative Strength Index (RSI)
- HCAI 38.61
- THAR 54.94
- Support Level
- HCAI $0.53
- THAR $2.85
- Resistance Level
- HCAI $0.58
- THAR $6.89
- Average True Range (ATR)
- HCAI 0.04
- THAR 0.51
- MACD
- HCAI -0.00
- THAR 0.03
- Stochastic Oscillator
- HCAI 33.31
- THAR 13.30
About HCAI Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares
Huachen AI Parking Management Technology Holding Co Ltd is a comprehensive smart parking solutions and equipment structural parts provider. The company manufactures and offer various cubic parking garage products by employing various working principles, such as lifting and shifting, convenient lifting, vertical circulation, vertical lifting, plane moving, alley stacking, multi-layer cycle, horizontal cycle, and car lift.
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.